Xenon Pharmaceuticals (XENE) Tops Q2 EPS by 9c

Xenon Pharmaceuticals (NASDAQ: XENE) reported Q2 EPS of ($0.07), $0.09 better than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Cerebras Q1 EPS miss sends shares down 9% after-hours
• After-Hours Stock Movers: FDX, CBRS, NKE